Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Usual/Permanent Night Shifts, Poor Sleep Quality Linked to Epilepsy

Night shifts and poor sleep quality are associated with an increased risk for incident epilepsy, according to a study published online Nov. 29 in BMC Public Hea

2010 to 2022 Saw Drop in Hospital-Based Obstetric Care in U.S. Hospitals

There was a net loss of hospital-based obstetric care in both rural and urban U.S. hospitals from 2010 to 2022, according to a research letter published online

What Works Best to Help Young Vapers Quit?

Many young adults can kick their vaping habit with a little coaching and support. New research published Dec. 10 in the American Journal of Preventive Medicine

'Brain Boost' From Today's Exercise May Linger Through Tomorrow

Want to give your brain a boost for tomorrow Get in a little pulse-pounding exercise today, a new study shows. In a finding that suggests the benefits of exerci

Genital Herpes Affects 1 in 5 Younger Adults Worldwide

Genital herpes is widespread the world round among younger adults, with more than 846 million people living with the lifelong sexually transmitted infection, a

Bird Flu in California Child Similar to Strain Seen in Livestock

As an outbreak of bird flu among dairy cows continues, U.S. health officials reported Tuesday that the strain of bird flu detected in a California child is simi

Jamie Foxx Reveals He Had Brain Bleed in 2023

Actor Jamie Foxx has shared the details of a life-threatening medical emergency he experienced last year after doctors discovered he had suffered a brain bleed.

uniQure Announces Alignment with FDA on Key Elements of Accelerated Approval Pathway for AMT-130 in Huntington’s Disease

uniQure N.V. (NASDAQ QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that the c

NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain

The antiviral drug tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild to moderate clade II mpox and a low

Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End

Chimerix (NASDAQ CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing d

Popular Keywords